Biologics in Severe Asthma: An Ideal Choice for Achieving Control-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biologics in Severe Asthma: An Ideal Choice for Achieving Control

Published:2024 Issue:3 Volume:16 Page:214
ISSN:2092-7355
Container-title:Allergy, Asthma & Immunology Research
language:en
Short-container-title:Allergy Asthma Immunol Res

Author:

Kim Sae-Hoon¹²³^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

2. Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.

3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Publisher

XMLink

Link

https://e-aair.org/pdf/10.4168/aair.2024.16.3.214

Reference11 articles.

1. Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma

2. The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma

3. Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR)

4. Biologic Therapies for Severe Asthma

5. Biologics for allergic and immunologic diseases

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP